BridgeBio Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 11/14/2024 | 25.26 M | $643.14 M | -18.67% | 13.40% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 25.12 M | $639.58 M | 0.00% | 13.33% |
| VANGUARD GROUP INC | 11/13/2024 | 14.20 M | $361.50 M | 1.03% | 7.53% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 12.88 M | $327.91 M | 100.00% | 6.83% |
| AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 6.07 M | $154.49 M | 0.00% | 3.22% |
| STATE STREET CORP | 11/14/2024 | 5.96 M | $151.81 M | 1.85% | 3.16% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.82 M | $122.66 M | 11.72% | 2.56% |
| UBS GROUP AG | 11/14/2024 | 4.11 M | $104.62 M | 6.36% | 2.18% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 3.89 M | $99.15 M | -11.27% | 2.07% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 3.76 M | $95.74 M | 3.52% | 1.99% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.41 M | $86.94 M | 3.75% | 1.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 3.14 M | $79.89 M | 4.91% | 1.66% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2.94 M | $74.91 M | 36.43% | 1.56% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 2.83 M | $71.99 M | 15.30% | 1.50% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 2.80 M | $71.12 M | 5.82% | 1.49% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 2.61 M | $66.56 M | 18.18% | 1.39% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.05 M | $52.24 M | -10.71% | 1.09% |
| JANE STREET GROUP, LLC | 11/15/2024 | 2.00 M | $50.86 M | 100.00% | 1.06% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 1.89 M | $48.01 M | 14.55% | 1.00% |
| SC US (TTGP), LTD. | 11/14/2024 | 1.86 M | $47.36 M | 0.00% | 0.99% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 1.86 M | $47.31 M | 0.00% | 0.99% |
| FMR LLC | 11/13/2024 | 1.82 M | $46.35 M | 18.21% | 0.97% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.75 M | $44.48 M | 100.00% | 0.93% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 1.53 M | $39.01 M | -0.18% | 0.81% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.45 M | $36.88 M | 14.54% | 0.77% |
| MORGAN STANLEY | 11/14/2024 | 1.38 M | $35.03 M | -3.73% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.28 M | $32.71 M | 8.04% | 0.68% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.22 M | $30.96 M | 590.67% | 0.65% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 1.15 M | $29.15 M | 1.78% | 0.61% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 1.10 M | $28.10 M | 65.61% | 0.59% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 1.09 M | $27.67 M | 35.85% | 0.58% |
| UBS GROUP AG | 11/14/2024 | 1.09 M | $27.67 M | -0.51% | 0.58% |
| HHLR ADVISORS, LTD. | 11/14/2024 | 1.02 M | $26.07 M | -26.37% | 0.54% |
| WOODLINE PARTNERS LP | 11/14/2024 | 949,749 | $24.18 M | 0.02% | 0.50% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 926,846 | $23.60 M | -15.49% | 0.49% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 906,724 | $23.09 M | -2.18% | 0.48% |
| INVESCO LTD. | 11/12/2024 | 857,457 | $21.83 M | -21.24% | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 842,644 | $21.45 M | -7.41% | 0.45% |
| MARSHALL WACE, LLP | 11/14/2024 | 833,236 | $21.21 M | 2,601.01% | 0.44% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 810,465 | $20.64 M | -1.74% | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 751,355 | $19.13 M | 50.80% | 0.40% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 748,819 | $19.06 M | 2.87% | 0.40% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 737,367 | $18.77 M | 23.25% | 0.39% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 716,927 | $18.25 M | 0.00% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 715,157 | $18.21 M | 5.69% | 0.38% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 681,300 | $17.35 M | 76.00% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 606,600 | $15.44 M | -28.77% | 0.32% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 552,000 | $14.05 M | -20.00% | 0.29% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 550,000 | $14.00 M | 175.00% | 0.29% |
| BARCLAYS PLC | 11/19/2024 | 545,008 | $13.88 M | 31.88% | 0.29% |
BridgeBio Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 314 institutional investors and hedge funds held shares of BridgeBio Pharma, Inc.. The most heavily invested institutionals were:
Kohlberg Kravis Roberts & Co. L.P.: 25.26 M
VIKING GLOBAL INVESTORS LP: 25.12 M
VANGUARD GROUP INC: 14.2 M
BlackRock Funding, Inc. /DE: 12.88 M
Aisling Capital Management LP: 6.07 M
STATE STREET CORP: 5.96 M
90.83% of BridgeBio Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 187.03 M shares in the last 24 months. This purchase volume represents approximately $4.95 B in transactions.